Synthesis and structure-activity relationships of skin ceramides

Current Medicinal Chemistry

Volumn 17, Issue 21, 2010, Pages 2301-2324

  Novotny J ^a   Hrabalek A ^a   Vavrova K ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Ceramides; Skin barrier; Sphingolipids; Sphingosine; Stratum corneum; Structure activity relationships; Synthesis

Indexed keywords

2 HYDROXYTETRACOSANOIC ACID; 30 (LINOLEYLOXY)TRIACONTANOIC ACID; 6 HYDROXYSPHINGOSINE; CERAMIDE; HYDROXY FATTY ACID; LINOLEIC ACID; OMEGA ACYLOXY FATTY ACID; PHYTOSPHINGOSINE; SPHINGANINE; SPHINGOSINE; UNCLASSIFIED DRUG; 6-HYDROXY-4-SPHINGENINE; SPHINGOLIPID;

ARTICLE; CONFORMATION; HUMAN; SKIN; SKIN PROTECTION; STEREOCHEMISTRY; STRATUM CORNEUM; STRUCTURE ACTIVITY RELATION; SYNTHESIS; ANALOGS AND DERIVATIVES; CHEMISTRY; EPIDERMIS; METABOLISM; PHYSIOLOGY; SKIN DISEASE;

CERAMIDES; EPIDERMIS; HUMANS; SKIN DISEASES; SPHINGOLIPIDS; SPHINGOSINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77955617285     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791331068     Document Type: Article

References (130)

1. Holleran, W. M.; Takagi, Y.; Uchida, Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett, 2006, 580, 5456-66.
2. Bouwstra, J. A.; Ponec, M. The skin barrier in healthy and diseased state. Biochim. Biophys. Acta, 2006, 1758, 2080-95.
3. Choi, M. J.; Maibach, H. I. Role of ceramides in barrier function of healthy and diseased skin. Am. J. Clin. Dermatol., 2005, 6, 215-23.
4. Feingold, K. R. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J. Lipid Res., 2007, 48, 2531-46.
5. Wertz, P. W. Lipids and barrier function of the skin. Acta. Derm. Venereol. Suppl. (Stockh), 2000, 208, 7-11.
6. Elias, P. M.; Feingold, K. R. Skin Barrier CRC Press: NY 2006.
7. Ogretmen, B.; Hannun, Y. A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer, 2004, 4, 604-16.
8. Goni, F. M.; Contreras, F. X.; Montes, L. R.; Sot, J.; Alonso, A. Biophysics (and sociology) of ceramides. Biochem. Soc. Symp., 2005, 177-88.
9. Morales, A.; Fernandez-Checa, J. C. Pharmacological modulation of sphingolipids and role in disease and cancer cell biology. Mini Rev. Med. Chem., 2007, 7, 371-82.
10. van Blitterswijk, W. J.; van der Luit, A. H.; Veldman, R. J.; Verheij, M.; Borst, J. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem. J., 2003, 369, 199-211.
11. Small, D. M. Surface and bulk interactions of lipids and water with a classification of biologically active lipids based on these interactions. Fed. Proc., 1970, 29, 1320-6.
12. Goni, F. M.; Alonso, A. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta, 2006, 1758, 1902-21.
13. Masukawa, Y.; Narita, H.; Shimizu, E.; Kondo, N.; Sugai, Y.; Oba, T.; Homma, R.; Ishikawa, J.; Takagi, Y.; Kitahara, T.; Takema, Y.; Kita, K. Characterization of overall ceramide species in human stratum corneum. J. Lipid Res., 2008, 49, 1466-76.
14. Motta, S.; Monti, M.; Sesana, S.; Caputo, R.; Carelli, S.; Ghidoni, R. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta, 1993, 1182, 147-51.
15. Pruett, S. T.; Bushnev, A.; Hagedorn, K.; Adiga, M.; Haynes, C. A.; Sullards, M. C.; Liotta, D. C.; Merrill, A. H., Jr. Biodiversity of sphingoid bases (sphingosines) and related amino alcohols. J. Lipid Res., 2008, 49, 1621-39.
16. Moore, D. J.; Rerek, M. E.; Mendelsohn, R. Role of ceramides 2 and 5 in the structure of the stratum corneum lipid barrier. Int. J. Cosmet. Sci., 1999, 21, 353-68.
17. Bouwstra, J. A.; Gooris, G. S.; Dubbelaar, F. E.; Weerheim, A. M.; Ijzerman, A. P.; Ponec, M. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J. Lipid Res., 1998, 39, 186-96.
18. Wertz, P. W.; Cho, E. S.; Downing, D. T. Effect of essential fatty acid deficiency on the epidermal sphingolipids of the rat. Biochim. Biophys. Acta., 1983, 753, 350-5.
19. de Jager, M.; Gooris, G.; Ponec, M.; Bouwstra, J. Acylceramide head group architecture affects lipid organization in synthetic ceramide mixtures. J. Invest. Dermatol., 2004, 123, 911-6.
20. Swartzendruber, D. C.; Wertz, P. W.; Madison, K. C.; Downing, D. T.Evidence that the corneocyte has a chemically bound lipid envelope. J. Invest. Dermatol., 1987, 88, 709-13.
21. Wertz, P. W.; Downing, D. T. Covalently bound omegahydroxyacylsphingosine in the stratum corneum. Biochim. Biophys. Acta, 1987, 917, 108-11.
22. Stewart, M. E.; Downing, D. T. The omega-hydroxyceramides of pig epidermis are attached to corneocytes solely through omegahydroxyl groups. J. Lipid Res., 2001, 42, 1105-10.
23. Wertz, P. W.; van den Bergh, B. The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids, 1998, 91, 85-96.
24. Alonso, A.; Meirelles, N. C.; Tabak, M. Lipid chain dynamics in stratum corneum studied by spin label electron paramagnetic resonance. Chem. Phys. Lipids, 2000, 104, 101-11.
25. Uchida, Y.; Holleran, W. M. Omega-O-acylceramide, a lipid essential for mammalian survival. J. Dermatol. Sci., 2008, 51, 77-87.
26. Lopez, O.; Cocera, M.; Wertz, P. W.; Lopez-Iglesias, C.; de la Maza, A. New arrangement of proteins and lipids in the stratum corneum cornified envelope. Biochim. Biophys. Acta, 2007, 1768, 521-9.
27. Vasireddy, V.; Uchida, Y.; Salem, N., Jr.; Kim, S. Y.; Mandal, M. N.; Reddy, G. B.; Bodepudi, R.; Alderson, N. L.; Brown, J. C.; Hama, H.; Dlugosz, A.; Elias, P. M.; Holleran, W. M.; Ayyagari, R. Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum. Mol. Genet., 2007, 16, 471-82.
28. Novotny, J.; Janusova, B.; Novotny, M.; Hrabalek, A.; Vavrova, K. Short-Chain Ceramides Decrease Skin Barrier Properties. Skin. Pharmacol. Physiol., 2009 22, 22-30.
29. Nybond, S.; Bjorkqvist, Y. J.; Ramstedt, B.; Slotte, J. P. Acyl chain length affects ceramide action on sterol/sphingomyelin-rich domains. Biochim. Biophys. Acta, 2005, 1718, 61-6.
30. Megha; Sawatzki, P.; Kolter, T.; Bittman, R.; London, E. Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts). Biochim. Biophys. Acta., 2007, 1768, 2205-12.
31. Chiantia, S.; Kahya, N.; Schwille, P. Raft domain reorganization driven by short- and long-chain ceramide: a combined AFM and FCS study. Langmuir, 2007, 23, 7659-65.
32. Gidwani, A.; Brown, H. A.; Holowka, D.; Baird, B. Disruption of lipid order by short-chain ceramides correlates with inhibition of phospholipase D and downstream signaling by FcepsilonRI. J. Cell. Sci., 2003, 116, 3177-87.
33. Vavrova, K.; Zbytovska, J.; Hrabalek, A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr. Med. Chem., 2005, 12, 2273-91.
34. Obeid, L. M.; Linardic, C. M.; Karolak, L. A.; Hannun, Y. A. Programmed cell death induced by ceramide. Science, 1993, 259, 1769-71.
35. Bielawska, A.; Crane, H. M.; Liotta, D.; Obeid, L. M.; Hannun, Y. A. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J. Biol. Chem., 1993, 268, 26226-32.
36. Brodesser, S.; Sawatzki, P.; Kolter, T. Bioorganic Chemistry of Ceramide. Eur. J. Org. Chem., 2003, 2021-2034.
37. Radin, N. S. Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria. Bioorg. Med. Chem., 2003, 11, 2123-42.
38. Radin, N. S. Meta-analysis of anticancer drug structures-- significance of their polar allylic moieties. Anticancer Agents Med. Chem., 2007, 7, 209-22.
39. Vavrova, K.; Hrabalek, A.; Mac-Mary, S.; Humbert, P.; Muret, P. Ceramide analogue 14S24 selectively recovers perturbed human skin barrier. Br. J. Dermatol., 2007, 157, 704-12.
40. Vavrova, K.; Zbytovska, J.; Palat, K.; Holas, T.; Klimentova, J.; Hrabalek, A.; Dolezal, P.Ceramide analogue 14S24 ((S)-2- tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. Eur. J. Pharm. Sci., 2004, 21, 581-7.
41. Brockman, H. L.; Momsen, M. M.; Brown, R. E.; He, L.; Chun, J.; Byun, H. S.; Bittman, R. The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophys. J., 2004, 87, 1722-31.
42. Li, L.; Tang, X.; Taylor, K. G.; DuPre, D. B.; Yappert, M. C. Conformational characterization of ceramides by nuclear magnetic resonance spectroscopy. Biophys. J., 2002, 82, 2067-80.
43. Novotny, M.; Hrabalek, A.; Janusova, B.; Novotny, J.; Vavrova, K. Dicarboxylic acid esters as transdermal permeation enhancers: effects of chain number and geometric isomers. Bioorg. Med. Chem. Lett., 2009, 19, 344-7.
44. Rerek, M. E.; Chen; Markovic, B.; Van Wyck, D.; Garidel, P.; Mendelsohn, R.; Moore, D. J. Phytosphingosine and Sphingosine Ceramide Headgroup Hydrogen Bonding: Structural Insights through Thermotropic Hydrogen/Deuterium Exchange. J. Phys. Chem. B, 2001, 105, 9355-9362.
45. Lofgren, H.; Pascher, I. Molecular arrangements of sphingolipids. The monolayer behaviour of ceramides. Chem. Phys. Lipids, 1977, 20, 273-84.
46. Forslind, B. A domain mosaic model of the skin barrier. Acta. Derm. Venereol., 1994, 74, 1-6.
47. Moore, D. J.; Rerek, M. E. Insights into the molecular organization of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. Acta. Derm. Venereol. Suppl. (Stockh), 2000, 208, 16-22.
48. Garidel, P. Calorimetric and spectroscopic investigations of phytosphingosine ceramide membrane organisation. Phys. Chem. Chem. Phys., 2002, 4, 1934-42.
49. Thudichum, J. L. W. A Treatise on the Chemical Constitution of the Brain, Tindall and Cox: London, Bailliere 1884.
50. Koskinen, P. i. M.; Koskinen, A. M. P. Sphingosine, an Enigmatic Lipid: A Review of Recent Literature Syntheses. Synthesis, 1998, 1998, 1075-1091.
51. Zellner, J. Zur Chemie des Fliegenpilzes (Amanita muscaria L.). Monatshefte für Chemie/Chemical Monthly, 1911, 32, 133-142.
52. Robson, K. J.; Stewart, M. E.; Michelsen, S.; Lazo, N. D.; Downing, D. T. 6-Hydroxy-4-sphingenine in human epidermal ceramides. J. Lipid. Res., 1994, 35, 2060-8.
53. Masuda, Y.; Mori, K. Synthesis and absolute configuration of 6- hydroxylated new ceramides in human skin, ceramides B, 4, 7 and 8. Eur. J. Org. Chem., 2005, 2005, 4789-4800.
54. Karlsson, K. A.; Pascher, I. Resolution and chromatographic configuration analysis of 2-hydroxy fatty acids. Chem. Phys. Lipids, 1974, 12, 65-74.
55. Heard, C. M.; Brain, K. R. Does solute stereochemistry influence percutaneous penetration? Chirality, 1995, 7, 305-9.
56. Reddy, I. K.; Kommuru, T. R.; Zaghloul, A. A.; Khan, M. A. Chirality and its implications in transdermal drug development. Crit. Rev. Ther. Drug Carrier Syst., 2000, 17, 285-325.
57. Vavrova, K.; Hrabalek, A.; Dolezal, P. Enhancement effects of (R) and (S) enantiomers and the racemate of a model enhancer on permeation of theophylline through human skin. Arch. Dermatol. Res., 2002, 294, 383-5.
58. Novotny, J.; Kovarikova, P.; Novotny, M.; Janusova, B.; Hrabalek, A.; Vavrova, K. Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination. Pharm. Res., 2009, 26, 811-21.
59. Norlen, L. Skin barrier structure and function: the single gel phase model. J. Invest. Dermatol., 2001, 117, 830-6.
60. Corkery, R. W.; Hyde, S. T. On the Swelling of Amphiphiles in Water. Langmuir, 1996, 12, 5528-5529.
61. Kiselev, M. A.; Ryabova, N. Y.; Balagurov, A. M.; Dante, S.; Hauss, T.; Zbytovska, J.; Wartewig, S.; Neubert, R. H.New insights into the structure and hydration of a stratum corneum lipid model membrane by neutron diffraction. Eur. Biophys. J., 2005, 34, 1030-40.
62. Corkery, R. W. The anti-parallel, extended or splayed-chain conformation of amphiphilic lipids. Colloid. Surf. B: Biointerfaces, 2002, 26, 3-20.
63. Kronke, M. Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes. Chem. Phys. Lipids, 1999, 101, 109-21.
64. Devant, R. M. Chemische Totalsynthese von Sphingosin, dem zentralen Baustein der Sphingolipide. Kontakte, 1992, 3, 11-28.
65. Howell, A. R.; Ndakala, A. J. The Preparation and Biological Significance of Phytosphingosines. Curr. Org. Chem., 2002, 6, 365-391.
66. Howell, A. R.; So, R. C.; Richardson, S. K. Approaches to the preparation of sphinganines. Tetrahedron, 2004, 60, 11327-11347.
67. Shapiro, D.; Segal, K. The synthesis of sphingosine. J. Am. Chem. Soc., 1954, 76, 5894-95.
68. Schmidt, R. R.; Zimmermann, P. Synthesis of d-erythrosphingosines. Tetrahedron Lett., 1986, 27, 481-484.
69. Kiso, M.; Nakamura, A.; Nakamura, J.; Tomita, Y.; Hasegawa, A. A Convenient synthesis of sphingosine and ceramide from Dxylose or D-galactose. J. Carbohydr. Chem., 1986, 5, 335-340.
70. Julina, R.; Herzig, T.; Bernet, B.; Vasella, A. Enantioselective Synthesis of D-erythro-Sphingosine and of Ceramide. Helv. Chim. Acta, 1986, 69, 368-373.
71. Garner, P.; Park, J. M.; Malecki, E. A stereodivergent synthesis of D-erythro-sphingosine and D-threo-sphingosine from L-serine. J. Org. Chem., 1988, 53, 4395-4398.
72. Herold, P. Synthesis of D-Erythro- and D-Threo-Sphingosine Derivatives From L-Serine. Helv. Chim. Acta, 1988, 71, 354-362.
73. Garner, P.; Park, J. M. 1,1,-Dimethylethyl (S)- or (R)-4-Formyl- 2,2-Dimethyl-3-Ooxazolidinecarboxylate: A Useful Serinal Derivative. Org. Synth., 1992, 9, 300.
74. Kobayashi, S.; Furuta, T. Use of heterocycles as chiral ligands and auxiliaries in asymmetric syntheses of sphingosine, sphingofungins B and F. Tetrahedron, 1998, 54, 10275-10294.
75. Hoffman, R. V.; Tao, J. A Synthesis of d-erythro- and l-threo- Sphingosine and Sphinganine Diastereomers via the Biomimetic Precursor 3-Ketosphinganine. J. Org. Chem., 1998, 63, 3979-3985.
76. Harris, B. D.; Joullié, M. M. Synthetic studies of didemnins. III: Syntheses of statine and isostatine stereoisomers. Tetrahedron, 1988, 44, 3489-3500.
77. Hoffman, R. V.; Tao, J. An Improved Enantiospecific Synthesis of Statine and Statine Analogs via 4-(N,N-Dibenzylamino)-3-keto Esters. J. Org. Chem., 1997, 62, 2292-2297.
78. Khiar, N.; Singh, K.; García, M.; Martín-Lomas, M. A short enantiodivergent synthesis of d-erythro and l-threo sphingosine. Tetrahedron Lett., 1999, 40, 5779-5782.
79. Solladie, G.; Hutt, J.; Girardin, A. Improved Preparation of Optically Active Methyl p-Tolyl Sulfoxide. Synthesis, 1987, 1987, 173-173.
80. Hertweck, C.; Boland, W. Asymmetric alpha-chloroallylboration of amino aldehydes: A novel and highly versatile route to d- and lerythro- sphingoid bases. J. Org. Chem., 1999, 64, 4426-4430.
81. Johnson, D. V.; Felfer, U.; Griengl, H. A chemoenzymatic access to D - and L -Sphingosines employing hydroxynitrile lyases. Tetrahedron, 2000, 56, 781-790.
82. He, L.; Byun, H.-S.; Bittman, R. Stereoselective preparation of ceramide and its skeleton backbone modified analogues via cyclic thionocarbonate intermediates derived by catalytic asymmetric dihydroxylation of,-unsaturated ester J. Org. Chem., 2000, 65, 7627-7633.
83. Barrett, A. G. M.; Sakadarat, S. Total syntheses of penicillanic acid S,S-dioxide and 6-aminopenicillanic acid using (benzyloxy) nitromethane. J. Org. Chem., 1990, 55, 5110-5117.
84. Nakamura, T.; Shiozaki, M. Stereoselective synthesis of D-erythrosphingosine and L-lyxo-phytosphingosine. Tetrahedron, 2001, 57, 9087-9092.
85. Duclos, R. I. The total syntheses of D-erythro-sphingosine, Npalmitoylsphingosine (ceramide), and glucosylceramide (cerebroside) via an azidosphingosine analog. Chem. Phys. Lipids, 2001, 111, 111-38.
86. Milne, J. E.; Jarowicki, K.; Kocienski, P. J.; Alonso, J. Synthesis of D-erythro-sphingosine and D-erythro-ceramide. Chem. Commun., 2002, 426-7.
87. Lee, J.-M.; Lim, H.-S.; Chung, S.-K. A short and efficient stereoselective synthesis of all four diastereomers of sphingosine. Tetrahedron Asymmetry, 2002, 13, 343-347.
88. Kang, S. H.; Hwang, Y. S.; Lee, H. S. A Stereocontrolled Synthesis of D-erythro-Sphingosine and D-ribo-Phytosphingsine. Bull. Korean Chem. Soc., 2002, 23, 1195-1196.
89. Olofsson, B.; Somfai, P. Divergent Synthesis of D-erythro- Sphingosine, L-threo-Sphingosine, and Their Regioisomers. J. Org. Chem., 2003, 68, 2514-2517.
90. Chun, J.; Li, G.; Byun, H.-S.; Bittman, R. A concise route to derythro- sphingosine from N-Boc-l-serine derivatives via sulfoxide or sulfone intermediates. Tetrahedron Lett., 2002, 43, 375-377.
91. van den Berg, R. J. B. H. N.; Korevaar, C. G. N.; van der Marel, G. A.; Overkleeft, H. S.; van Boom, J. H. A simple and low cost synthesis of d-erythro-sphingosine and d-erythro-azidosphingosine from d-ribo-phytosphingosine: glycosphingolipid precursors. Tetrahedron Lett., 2002, 43, 8409-8412.
92. Wild, R.; Schmidt, R. R. Sphingosine and phytosphingosine from D-threose synthesis of a 4-keto-ceramide. Tetrahedron Asymmetry, 1994, 5, 2195-2208.
93. van den Berg, R. J.; Korevaar, C. G.; Overkleeft, H. S.; van der Marel, G. A.; van Boom, J. H. Effective, high-yielding, and stereospecific total synthesis of D-erythro-(2R,3S)-sphingosine from Dribo-(2S,3S,4R)-phytosphingosine. J. Org. Chem., 2004, 69, 5699-704.
94. Kolb, H. C.; Sharpless, K. B. A simplified procedure for the stereospecific transformation of 1,2-diols into epoxides. Tetrahedron, 1992, 48, 10515-10530.
95. Szeja, W. Phase Transfer-Catalyzed preparation of oxiranes. Synthesis, 1985, 983-985.
96. Raghavan, S.; Rajender, A. Novel, short, stereospecific synthesis of lyxo-(2R,3R,4R)-phytosphingosine and erythro-(2R,3S)- sphingosine. J. Org. Chem., 2003, 68, 7094-7.
97. Torssell, S.; Somfai, P. A practical synthesis of D-erythrosphingosine using a cross-metathesis approach. Org. Biomol. Chem., 2004, 2, 1643-1646.
98. Romero, A.; Wong, C.-H.Chemo-Enzymatic total synthesis of 3- Epiaustraline, Australine, and 7-Epialexine. J. Org. Chem., 2000, 65, 8264-8268.
99. Rai, A. N.; Basu, A. Synthesis of the glycosphingolipid β- galactosyl ceramide and analogues via olefin cross metathesis. J. Org. Chem., 2005, 70, 8228-8230.
100. Rai, A. N.; Basu, A. Sphingolipid synthesis via olefin cross metathesis: preparation of a differentially protected building block and application to the synthesis of D-erythro-ceramide. Org. Lett., 2004, 6, 2861-2863.
101. Bundle, D.; Ling, C. C., 2003; Vol. WO/2003/101937.
102. Lu, X.; Bittman, R.Efficient and versatile synthesis of (2S,3R)- sphingosine and its 2-azido-3-O-benzylsphingosine analogue. Tetrahedron Lett., 2005, 46, 1873-1875.
103. Disadee, W.; Ishikawa, T. Chirality transfer from guanidinium ylides to 3-alkenyl (or 3-alkynyl) aziridine-2-carboxylates and application to the syntheses of (2R,3S)-3-hydroxyleucinate and Derythro- sphingosine. J. Org. Chem., 2005, 70, 9399-406.
104. Chaudhari, V. D.; Kumar, K. S. A.; Dhavale, D. D. An Efficient Synthesis of D-erythro- and D-threo-Sphingosine from D-Glucose: Olefin Cross-Metathesis approach. Org. Lett., 2005, 7, 5805-5807.
105. Gruner, S. A. W.; Kéri, G.; Schwab, R.; Venetianer, A.; Kessler, H. Sugar amino acid containing somatostatin analogues that induce apoptosis in both drug-sensitive and multidrug-resistant tumor cells. Org. Lett., 2001, 6, 3723-3725.
106. Merino, P.; Jimenez, P.; Tejero, T. Enantiodivergent Synthesis of D- and L-erythro-Sphingosines through Mannich-Type Reactions of N-Benzyl-2,3-O-isopropylidene-D-glyceraldehyde Nitrone. J. Org. Chem., 2006, 71, 4685-4688.
107. Merino, P.; Franco, S.; Merchan, F. L.; Tejero, T. Diastereoselective nucleophilic addition of acetylide to N-benzyl-2,3-Oisopropylidene- D-glyceraldehyde nitrone (BIGN). Stereodivergent synthesis of 13-hydroxy-oc-(hydroxyamino)- and 13-hydroxy- o - amino acids. Tetrahedron Asymmetry, 1997, 8, 3489-3496.
108. Hamura, T.; Hosoya, T.; Yamaguchi, H.; Kuriyama, Y.; Tanabe, M.; Miyamoto, M.; Yasui, Y.; Matsumoto, T.; Suzuki, K. Facile Access to Versatile Polyaromatic Building Blocks: Selectively Protected Benzocyclobutenedione Derivatives via Regioselective [2+2] Cycloaddition of -Alkoxybenzyne and Ketene Silyl Acetal. Tetrahedron Asymmetry, 2002, 85, 3589-3604.
109. Kim, S.; Lee, S.; Lee, T.; Ko, H.; Kim, D. Efficient Synthesis of Derythro- Sphingosine and D-erythro-Azidosphingosine from D-ribo- Phytosphingosine via a Cyclic Sulfate Intermediate. J. Org. Chem., 2006, 71, 8661-8664.
110. Righi, G.; Ciambrone, S.; D'Achille, C.; Leonelli, A.; Bonini, C. Highly efficient stereoselective synthesis of d-erythro-sphingosine and d-lyxo-phytosphingosine. Tetrahedron, 2006, 62, 11821-11826.
111. Tuch, A.; Saniere, M.; Le Merrer, Y.; Depezay, J.-C. Enantiopure Aminotriol from D-Isoascorbic Acid. Synthesis of D-Threo-C-18- Sphingosine. Tetrahedron Asymmetry, 1996, 7, 897-906.
112. Yamamoto, T.; Hasegawa, H.; Hakogi, T.; Katsumura, S. Versatile synthetic method for sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis. Org. Lett., 2006, 8, 5569-5572.
113. Pham, V. T.; Joo, J. E.; Tian, Y. S.; Oh, C. Y.; Ham, W. H. A concise synthesis of a promising protein kinase C inhibitor: D-erythrosphingosine. Arch. Pharm. Res., 2007, 30, 22-7.
114. Yang, H.; Liebeskind, L. S. A Concise and Scalable Synthesis of High Enantiopurity (-)-D-erythro-Sphingosine Using Peptidyl Thiol Ester-Boronic Acid Cross-Coupling. Org. Lett., 2007, 9, 2993-2995.
115. Stewart, M. E.; Downing, D. T. A new 6-hydroxy-4-sphingeninecontaining ceramide in human skin. J. Lipid. Res., 1999, 40, 1434-9.
116. Chun, J.; Byun, H.-S.; Bittman, R. First Asymmetric Synthesis of 6-Hydroxy-4-Sphingenine-Containing Ceramides. Use of Chiral Propargylic Alcohols To Prepare a Lipid Found in Human Skin. J. Org. Chem., 2003, 68, 348-354.
117. Yadav, J. S.; Geetha, V.; Krishnam, R. A.; Gnaneshwar, D.; Chandrasekhar, S. The first total synthesis of the 6-hydroxy-4Esphingenines. Tetrahedron Lett., 2003, 44, 2983-2985.
118. Mori, K.; Masuda, Y. Synthesis and stereochemistry of ceramide B, (2S,3R,4E,6R)-N-(30-hydroxytriacontanoyl)-6-hydroxy-4- sphingenine, a new ceramide in human epidermis. Tetrahedron Lett., 2003, 44, 9193-9196.
119. Mori, K.; Matsuda, H. Synthesis of sphingosine relatives, X. Synthesis of (2S,3R,4E)-1-O-(β-D-glucopyranosyl)-N-[30'- (linoleoyloxy)triacontanoyl]-4-icosasphingenine, a new esterified cerebroside isolated from human and pig epidermis. Liebigs Ann. Chem., 1991, 1991, 529-535.
120. Müller, S.; Schmidt, R. R. Synthesis of two unique compounds, a ceramide and a cerebroside, occurring in human stratum corneum. J. Prakt. Chem., 2000, 342, 779-784.
121. Koike, K.; Sugimoto, M.; Nakahara, Y.; Ogawa, T. Total synthesis of cerebrosides: (2S, 3R, 4E)-1-O-β--galactopyranosyl-N-(2βR and 2βS)-2β-hydroxytetracosanoylsphingenine. Carbohydr. Res., 1987, 162, 237-246.
122. Horn, D. H. S.; Pretorius, Y. Y. Wool wax. Part VI. The synthesis and stereochemistry of the straight-chain β-hydroxy-acids. J. Chem. Soc., 1954, 1460-1464.
123. Mitsunobu, O.; Eguchi, M. Preparation of carboxylic esters and phosphoric esters by the activation of alcohols. Bull. Chem. Soc. Jpn., 1971, 44, 237-246.
124. Van den Berg, M. A.; Streekstra, H. European Patent Office, ed., 2007; Vol. EP1767644 (A1).
125. Kessner, D.; Ruettinger, A.; Kiselev, M. A.; Wartewig, S.; Neubert, R. H. Properties of ceramides and their impact on the stratum corneum structure. Part 2: stratum corneum lipid model systems. Skin. Pharmacol. Physiol., 2008, 21, 58-74.
126. Gooris, G. S.; Bouwstra, J. A. Infrared spectroscopic study of stratum corneum model membranes prepared from human ceramides, cholesterol, and fatty acids. Biophys. J., 2007, 92, 2785-95.
127. de Jager, M.; Groenink, W.; Bielsa i Guivernau, R.; Andersson, E.; Angelova, N.; Ponec, M.; Bouwstra, J. A novel in vitro percutaneous penetration model: evaluation of barrier properties with paminobenzoic acid and two of its derivatives. Pharm. Res., 2006, 23, 951-60.
128. de Jager, M.; Groenink, W.; Bielsa, I. G. R.; Andersson, E.; Angelova, N.; Ponec, M.; Bouwstra, J. A Novel in Vitro Percutaneous Penetration Model: Evaluation of Barrier Properties with PAminobenzoic Acid and Two of Its Derivatives. Pharm. Res., 2006.
129. de Jager, M.; Groenink, W.; van der Spek, J.; Janmaat, C.; Gooris, G.; Ponec, M.; Bouwstra, J. Preparation and characterization of a stratum corneum substitute for in vitro percutaneous penetration studies. Biochim. Biophys. Acta., 2006, 1758, 636-44.
130. Groen, D.; Gooris, G. S.; Ponec, M.; Bouwstra, J. A. Two new methods for preparing a unique stratum corneum substitute. Biochim. Biophys. Acta, 2008, 1778, 2421-9.